Evaluation of white blood cell count as a possible prognostic marker for oral cancer

Head and Neck Oncology

Volumn 3, Issue 1, 2011, Pages

  Kruse, Astrid L ^a   Luebbers, Heinz T ^a   Grätz, Klaus W ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; FOLLOW UP; GENDER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUTH CANCER; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; BLOOD; EVALUATION; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; PREDICTIVE VALUE; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LEUKOCYTE COUNT; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT;

EID: 79951946415     PISSN: None     EISSN: 17583284     Source Type: Journal    
DOI: 10.1186/1758-3284-3-13     Document Type: Article

References (18)

1. Inflammation and cancer. LM Coussens Z Werb, Nature 2002 420 6917 860 7 10.1038/nature01322 12490959 (Pubitemid 36019639)
2. A prospective study of serum C-reactive protein and colorectal cancer risk in men. MJ Gunter R Stolzenberg-Solomon AJ Cross MF Leitzmann S Weinstein RJ Wood J Virtamo PR Taylor D Albanes R Sinha, Cancer Res 2006 66 4 2483 7 10.1158/0008-5472.CAN-05-3631 16489056
3. Is C-reactive protein a prognostic factor of colorectal cancer? YC Shiu JK Lin CJ Huang JK Jiang LW Wang HC Huang SH Yang, Dis Colon Rectum 2008 51 4 443 9 10.1007/s10350-007-9133-z 18172726
4. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. C Siemes LE Visser JW Coebergh TA Splinter JC Witteman AG Uitterlinden A Hofman HA Pols BH Stricker, J Clin Oncol 2006 24 33 5216 22 10.1200/JCO.2006.07.1381 17114654 (Pubitemid 46631365)
5. Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma. SD Khandavilli PO Ceallaigh CJ Lloyd R Whitaker, Oral Oncol 2009 45 10 912 4 10.1016/j.oraloncology.2009.03.015 19502100
6. Serum Levels of IL-1b, IL-6, TNF-a, sTNF-RI and CRP in Patients with Oral Cavity Cancer. E Jablonska L Piotrowski Z Grabowska, Pathol Oncol Res 1997 3 2 126 129 10.1007/BF02907807 11173639
7. Prognostic importance of the white blood cell count for coronary, cancer, and all-cause mortality. RH Grimm Jr JD Neaton W Ludwig, JAMA 1985 254 14 1932 7 10.1001/jama.254.14.1932 4046122 (Pubitemid 15249094)
8. White blood cell count and the risk of colon cancer. YJ Lee HR Lee CM Nam UK Hwang SH Jee, Yonsei Med J 2006 47 5 646 56 10.3349/ymj.2006.47.5.646 17066508
9. Association between circulating white blood cell count and long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. A Shankar P Mitchell E Rochtchina J Tan JJ Wang, Am J Epidemiol 2007 165 4 375 82 10.1093/aje/kwk022 17110636
10. Cancer and the chemokine network. F Balkwill, Nat Rev Cancer 2004 4 7 540 50 10.1038/nrc1388 15229479 (Pubitemid 38868623)
11. White blood cell count and risk for all-cause, cardiovascular, and cancer mortality in a cohort of Koreans. SH Jee JY Park HS Kim TY Lee JM Samet, Am J Epidemiol 2005 162 11 1062 9 10.1093/aje/kwi326 16221804 (Pubitemid 41746618)
12. Leukocyte count and coronary heart disease: implications for risk assessment. M Madjid I Awan JT Willerson SW Casscells, J Am Coll Cardiol 2004 44 10 1945 56 10.1016/j.jacc.2004.07.056 15542275 (Pubitemid 39473277)
13. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and White men and women: atherosclerosis risk in communities study. CD Lee AR Folsom FJ Nieto LE Chambless E Shahar DA Wolfe, Am J Epidemiol. 2001 Oct 15 154 8 758 64 10.1093/aje/154.8.758
14. WBC count and the risk of cancer mortality in a national sample of U.S. adults: results from the Second National Health and Nutrition Examination Survey mortality study. TP Erlinger P Muntner KJ Helzlsouer, Cancer Epidemiol Biomarkers Prev 2004 13 6 1052 6 15184263 (Pubitemid 38756717)
15. Genetic tools to tailor cancer prevention by NSAIDs. CM Ulrich J Bigler JD Potter, Discov Med 2006 6 32 71 4 17234129
16. Interleukin-6 and acute-phase proteins in head and neck cancer. O Gallo AM Gori M Attanasio F Martini B Giusti T Brunelli E Gallina, Eur Arch Otorhinolaryngol 1995 252 3 159 62 10.1007/BF00178104 7544987
17. C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer. Y Ki W Kim J Nam D Kim D Park D Kim, Int J Radiat Oncol Biol Phys 2009 75 2 393 8 10.1016/j.ijrobp.2008.11.012 19362778
18. Leukocytes and coronary hear disease. M Hoffman A Blum R Baruch E Kaplan M Benjamin, Atherosclerosis 2004 172 1 1 6 10.1016/S0021-9150(03)00164-3 14709350